Correction to: Whole exome sequencing identifies novel candidate genes that modify chronic obstructive pulmonary disease susceptibility (Human Genomics, (2016), 10, 1, (1), 10.1186/s40246-015-0058-7);Whole exome sequencing identifies novel candidate genes that modify chronic obstructive pulmonary disease susceptibility

Human Genomics

Volumn 10, Issue 1, 2016, Pages

  Bruse, Shannon ^a   Moreau, Michael ^b   Bromberg, Yana ^b   Jang, Jun Ho ^a,c   Wang, Nan ^b   Ha, Hongseok ^b   Picchi, Maria ^a   Lin, Yong ^a   Langley, Raymond J ^a   Qualls, Clifford ^d   Klensney Tait, Julia ^e   Zabner, Joseph ^e   Leng, Shuguang ^a   Mao, Jenny ^c   Belinsky, Steven A ^a   Xing, Jinchuan ^b   Nyunoya, Toru ^a,c  

^a LOVELACE RESPIRATORY RESEARCH INSTITUTE   (United States)

^b RUTGERS UNIVERSITY   (United States)

^c NEW MEXICO VA HEALTH CARE SYSTEM   (United States)

^d New Mexico Institute of Neuroimaging   (United States)

^e UNIVERSITY OF IOWA   (United States)

Author keywords

Cigarette smoke; COPD; Resistant smokers; Susceptible smokers; Whole exome sequencing

Indexed keywords

CIGARETTE SMOKE; SMALL INTERFERING RNA;

AGED; ARTICLE; CASE CONTROL STUDY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; CYTOTOXICITY; EPITHELIUM CELL; EXOME; FEMALE; FOLLOW UP; GENE FREQUENCY; GENE SEQUENCE; GENE SILENCING; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; IN VITRO STUDY; LUNG ALVEOLUS EPITHELIUM CELL; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; SMOKING; ADVERSE EFFECTS; CELL SURVIVAL; GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; GENETICS; HIGH THROUGHPUT SEQUENCING; MIDDLE AGED; PATHOLOGY; PRIMARY CELL CULTURE; PROCEDURES;

AGED; CELL SURVIVAL; EXOME; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MALE; MIDDLE AGED; PHENOTYPE; PRIMARY CELL CULTURE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKING;

EID: 84954075683     PISSN: 14739542     EISSN: 14797364     Source Type: Journal    
DOI: 10.1186/s40246-021-00373-w     Document Type: Erratum

References (59)

1. Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2163-96. doi: 10.1016/S0140-6736(12)61729-2.
2. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2095-128. doi: 10.1016/S0140-6736(12)61728-0.
3. Lokke A, Lange P, Scharling H, Fabricius P, Vestbo J. Developing COPD: a 25 year follow up study of the general population. Thorax. 2006;61(11):935-9. doi: 10.1136/thx.2006.062802.
4. Silverman EK. Progress in chronic obstructive pulmonary disease genetics. Proc Am Thorac Soc. 2006;3(5):405-8. doi: 10.1513/pats.200603-092AW.
5. Janus ED, Phillips NT, Carrell RW. Smoking, lung function, and alpha 1-antitrypsin deficiency. Lancet. 1985;1(8421):152-4.
6. Thun GA, Ferrarotti I, Imboden M, Rochat T, Gerbase M, Kronenberg F, et al. SERPINA1 PiZ and PiS heterozygotes and lung function decline in the SAPALDIA cohort. PLoS One. 2012;7(8):e42728. doi: 10.1371/journal.pone.0042728.
7. American Thoracic Society/European Respiratory Society statement: standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency. Am J Respir Crit Care Med. 2003;168 (7):818-900. doi: 10.1164/rccm.168.7.818
8. Cho MH, Boutaoui N, Klanderman BJ, Sylvia JS, Ziniti JP, Hersh CP, et al. Variants in FAM13A are associated with chronic obstructive pulmonary disease. Nat Genet. 2010;42(3):200-2. doi: 10.1038/ng.535.
9. Wilk JB, Shrine NR, Loehr LR, Zhao JH, Manichaikul A, Lopez LM, et al. Genome-wide association studies identify CHRNA5/3 and HTR4 in the development of airflow obstruction. Am J Respir Crit Care Med. 2012;186(7):622-32. doi: 10.1164/rccm.201202-0366OC.
10. Cho MH, Castaldi PJ, Wan ES, Siedlinski M, Hersh CP, Demeo DL, et al. A genome-wide association study of COPD identifies a susceptibility locus on chromosome 19q13. Hum Mol Genet. 2012;21(4):947-57. doi: 10.1093/hmg/ddr524.
11. Hersh CP, Pillai SG, Zhu G, Lomas DA, Bakke P, Gulsvik A, et al. Multistudy fine mapping of chromosome 2q identifies XRCC5 as a chronic obstructive pulmonary disease susceptibility gene. Am J Respir Crit Care Med. 2010;182(5):605-13. doi: 10.1164/rccm.200910-1586OC.
12. Fu W, O'Connor TD, Jun G, Kang HM, Abecasis G, Leal SM, Gabriel S, Rieder MJ, Altshuler D, Shendure J, Nickerson DA, Bamshad MJ, Project NES, Akey JM. Analysis of 6,515 exomes reveals the recent origin of most human protein-coding variants. Nature. 2013;493(7431):216-20. doi: 10.1038/nature11690.
13. Wain LV, Sayers I, Soler Artigas M, Portelli MA, Zeggini E, Obeidat M, et al. Whole exome re-sequencing implicates CCDC38 and cilia structure and function in resistance to smoking related airflow obstruction. PLoS Genet. 2014;10(5):e1004314. doi: 10.1371/journal.pgen.1004314.
14. Barnett IJ, Lee S, Lin X. Detecting rare variant effects using extreme phenotype sampling in sequencing association studies. Genet Epidemiol. 2013;37(2):142-51. doi: 10.1002/gepi.21699.
15. Nyunoya T, Mebratu Y, Contreras A, Delgado M, Chand HS, Tesfaigzi Y. Molecular processes that drive cigarette smoke-induced epithelial cell fate of the lung. Am J Respir Cell Mol Biol. 2014;50(3):471-82. doi: 10.1165/rcmb.2013-0348TR.
16. Petrache I, Natarajan V, Zhen L, Medler TR, Richter AT, Cho C, et al. Ceramide upregulation causes pulmonary cell apoptosis and emphysema-like disease in mice. Nat Med. 2005;11(5):491-8. doi: 10.1038/nm1238.
17. Aoshiba K, Zhou F, Tsuji T, Nagai A. DNA damage as a molecular link in the pathogenesis of COPD in smokers. Eur Respir J. 2012. doi: 10.1183/09031936.00050211
18. Hu H, Huff CD, Moore B, Flygare S, Reese MG, Yandell M. VAAST 2.0: improved variant classification and disease-gene identification using a conservation-controlled amino acid substitution matrix. Genet Epidemiol. 2013;37(6):622-34. doi: 10.1002/gepi.21743.
19. Yandell M, Huff C, Hu H, Singleton M, Moore B, Xing J, et al. A probabilistic disease-gene finder for personal genomes. Genome Res. 2011;21(9):1529-42. doi: 10.1101/gr.123158.111.
20. Kamburov A, Stelzl U, Lehrach H, Herwig R. The ConsensusPathDB interaction database: 2013 update. Nucleic Acids Res. 2013;41(Database issue):D793-800. doi: 10.1093/nar/gks1055.
21. Kamburov A, Stelzl U, Herwig R. IntScore: a web tool for confidence scoring of biological interactions. Nucleic Acids Res. 2012;40(Web Server issue):W140-146. doi: 10.1093/nar/gks492.
22. Treutlein B, Brownfield DG, Wu AR, Neff NF, Mantalas GL, Espinoza FH, et al. Reconstructing lineage hierarchies of the distal lung epithelium using single-cell RNA-seq. Nature. 2014;509(7500):371-5. doi: 10.1038/nature13173.
23. Manolio TA, Collins FS, Cox NJ, Goldstein DB, Hindorff LA, Hunter DJ, et al. Finding the missing heritability of complex diseases. Nature. 2009;461(7265):747-53. doi: 10.1038/nature08494.
24. Eichler EE, Flint J, Gibson G, Kong A, Leal SM, Moore JH, et al. Missing heritability and strategies for finding the underlying causes of complex disease. Nat Rev Genet. 2010;11(6):446-50. doi: 10.1038/nrg2809.
25. Gibson G. Rare and common variants: twenty arguments. Nat Rev Genet. 2011;13(2):135-45. doi: 10.1038/nrg3118.
26. Kryukov GV, Pennacchio LA, Sunyaev SR. Most rare missense alleles are deleterious in humans: implications for complex disease and association studies. Am J Hum Genet. 2007;80(4):727-39. doi: 10.1086/513473.
27. Schork NJ, Murray SS, Frazer KA, Topol EJ. Common vs. rare allele hypotheses for complex diseases. Curr Opin Genet Dev. 2009;19(3):212-9. doi: 10.1016/j.gde.2009.04.010.
28. Eisner MD, Anthonisen N, Coultas D, Kuenzli N, Perez-Padilla R, Postma D, et al. An official American Thoracic Society public policy statement: novel risk factors and the global burden of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2010;182(5):693-718. doi: 10.1164/rccm.200811-1757ST.
29. Ha GH, Kim JL, Breuer EK. Transforming acidic coiled-coil proteins (TACCs) in human cancer. Cancer Lett. 2013;336(1):24-33. doi: 10.1016/j.canlet.2013.04.022.
30. Schuendeln MM, Piekorz RP, Wichmann C, Lee Y, McKinnon PJ, Boyd K, et al. The centrosomal, putative tumor suppressor protein TACC2 is dispensable for normal development, and deficiency does not lead to cancer. Mol Cell Biol. 2004;24(14):6403-9. doi: 10.1128/MCB.24.14.6403-6409.2004.
31. Mele C, Iatropoulos P, Donadelli R, Calabria A, Maranta R, Cassis P, et al. MYO1E mutations and childhood familial focal segmental glomerulosclerosis. N Engl J Med. 2011;365(4):295-306. doi: 10.1056/NEJMoa1101273.
32. Wenzel J, Ouderkirk JL, Krendel M, Lang R. Class I myosin Myo1e regulates TLR4-triggered macrophage spreading, chemokine release, and antigen presentation via MHC class II. Eur J Immunol. 2015;45(1):225-37. doi: 10.1002/eji.201444698.
33. Kanemaru K, Nakahara M, Nakamura Y, Hashiguchi Y, Kouchi Z, Yamaguchi H, et al. Phospholipase C-eta2 is highly expressed in the habenula and retina. Gene Expr Patterns. 2010;10(2-3):119-26. doi: 10.1016/j.gep.2009.12.004.
34. Horiba N, Masuda S, Takeuchi A, Takeuchi D, Okuda M, Inui K. Cloning and characterization of a novel Na+-dependent glucose transporter (NaGLT1) in rat kidney. J Biol Chem. 2003;278(17):14669-76. doi: 10.1074/jbc.M212240200.
35. Ogawa F, Adachi S, Kohu K, Shige K, Akiyama T. Binding of the human homolog of the Drosophila discs large tumor suppressor protein to the mitochondrial ribosomal protein MRP-S34. Biochem Biophys Res Commun. 2003;300(3):789-92.
36. Hautamaki RD, Kobayashi DK, Senior RM, Shapiro SD. Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. Science (New York, NY). 1997;277(5334):2002-4.
37. Nakanishi K, Takeda Y, Tetsumoto S, Iwasaki T, Tsujino K, Kuhara H, et al. Involvement of endothelial apoptosis underlying chronic obstructive pulmonary disease-like phenotype in adiponectin-null mice: implications for therapy. Am J Respir Crit Care Med. 2011;183(9):1164-75. doi: 10.1164/rccm.201007-1091OC.
38. Woodruff PG, Koth LL, Yang YH, Rodriguez MW, Favoreto S, Dolganov GM, et al. A distinctive alveolar macrophage activation state induced by cigarette smoking. Am J Respir Crit Care Med. 2005;172(11):1383-92. doi: 10.1164/rccm.200505-686OC.
39. Carolan BJ, Harvey BG, Hackett NR, O'Connor TP, Cassano PA, Crystal RG. Disparate oxidant gene expression of airway epithelium compared to alveolar macrophages in smokers. Respir Res. 2009;10:111. doi: 10.1186/1465-9921-10-111.
40. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007;176(6):532-55.
41. DePristo MA, Banks E, Poplin R, Garimella KV, Maguire JR, Hartl C, et al. A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat Genet. 2011;43(5):491-8. doi: 10.1038/ng.806.
42. Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. 2009;25(14):1754-60. doi: 10.1093/bioinformatics/btp324.
43. McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 2010;20(9):1297-303. doi: 10.1101/gr.107524.110.
44. Wang K, Li M, Hakonarson H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 2010;38(16):e164. doi: 10.1093/nar/gkq603.
45. Reese MG, Moore B, Batchelor C, Salas F, Cunningham F, Marth GT, et al. A standard variation file format for human genome sequences. Genome Biol. 2010;11(8):R88. doi: 10.1186/gb-2010-11-8-r88.
46. Genomes Project C, Abecasis GR, Altshuler D, Auton A, Brooks LD, Durbin RM, Gibbs RA, Hurles ME, McVean GA. A map of human genome variation from population-scale sequencing. Nature. 2010;467(7319):1061-73. doi: 10.1038/nature09534.
47. Li Y, Vinckenbosch N, Tian G, Huerta-Sanchez E, Jiang T, Jiang H, et al. Resequencing of 200 human exomes identifies an excess of low-frequency non-synonymous coding variants. Nat Genet. 2010;42(11):969-72. doi: 10.1038/ng.680.
48. Drmanac R, Sparks AB, Callow MJ, Halpern AL, Burns NL, Kermani BG, et al. Human genome sequencing using unchained base reads on self-assembling DNA nanoarrays. Science. 2010;327(5961):78-81. doi: 10.1126/science.1181498.
49. Bromberg Y, Rost B. SNAP: predict effect of non-synonymous polymorphisms on function. Nucleic Acids Res. 2007;35(11):3823-35. doi: 10.1093/nar/gkm238.
50. Yu L, Liu H. Feature selection for high-dimensional data: a fast correlation-based filter solution. Proceedings of the twentieth international conference on machine learning. 2003. p. 856-63.
51. Hall M, Frank E, Holmes G, Pfahringer B, Reutemann P, Wittn I. The WEKA data mining software: an update. ACM SIGKDD Explor Newsl. 2009;11(1):10-8.
52. Quinlan JR. Book Review: C4.5: programs for machine learning. Mach Learn. 1993;16:235-40.
53. Jang JH, Bruse S, Liu Y, Duffy V, Zhang C, Oyamada N, et al. Aldehyde dehydrogenase 3A1 protects airway epithelial cells from cigarette smoke-induced DNA damage and cytotoxicity. Free Radic Biol Med. 2014;68:80-6. doi: 10.1016/j.freeradbiomed.2013.11.028.
54. Ramirez RD, Sheridan S, Girard L, Sato M, Kim Y, Pollack J, et al. Immortalization of human bronchial epithelial cells in the absence of viral oncoproteins. Cancer Res. 2004;64(24):9027-34. doi: 10.1158/0008-5472.CAN-04-3703.
55. Jang JH, Bruse S, Liu Y, Duffy V, Zhang C, Oyamada N, et al. Aldehyde dehydrogenase 3A1 protects airway epithelial cells from cigarette smoke-induced DNA damage and cytotoxicity. Free Radic Biol Med. 2013;68C:80-6. doi: 10.1016/j.freeradbiomed.2013.11.028.
56. Nyunoya T, Monick MM, Klingelhutz AL, Glaser H, Cagley JR, Brown CO, et al. Cigarette smoke induces cellular senescence via Werner's syndrome protein down-regulation. Am J Respir Crit Care Med. 2009;179(4):279-87. doi: 10.1164/rccm.200802-320OC.
57. Trapnell C, Roberts A, Goff L, Pertea G, Kim D, Kelley DR, et al. Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nat Protoc. 2012;7(3):562-78. doi: 10.1038/nprot.2012.016.
58. Chand HS, Montano G, Huang X, Randell SH, Mebratu Y, Petersen H, et al. A genetic variant of p53 restricts the mucous secretory phenotype by regulating SPDEF and Bcl-2 expression. Nat Commun. 2014;5:5567. doi: 10.1038/ncomms6567.
59. Shi S, Wang Q, Xu J, Jang JH, Padilla MT, Nyunoya T, et al. Synergistic anticancer effect of cisplatin and Chal-24 combination through IAP and c-FLIPL degradation, Ripoptosome formation and autophagy-mediated apoptosis. Oncotarget. 2015;6(3):1640-51.